rs551990619
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_178452.6(DNAAF1):c.112G>A(p.Gly38Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00115 in 1,548,882 control chromosomes in the GnomAD database, including 41 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_178452.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAAF1 | NM_178452.6 | c.112G>A | p.Gly38Ser | missense_variant | 1/12 | ENST00000378553.10 | NP_848547.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAAF1 | ENST00000378553.10 | c.112G>A | p.Gly38Ser | missense_variant | 1/12 | 1 | NM_178452.6 | ENSP00000367815 | P1 | |
DNAAF1 | ENST00000567918.5 | c.112G>A | p.Gly38Ser | missense_variant, NMD_transcript_variant | 1/7 | 1 | ENSP00000455154 | |||
DNAAF1 | ENST00000570298.5 | n.266G>A | non_coding_transcript_exon_variant | 1/11 | 2 | |||||
DNAAF1 | ENST00000563093.5 | c.112G>A | p.Gly38Ser | missense_variant, NMD_transcript_variant | 1/11 | 2 | ENSP00000457373 |
Frequencies
GnomAD3 genomes AF: 0.000644 AC: 98AN: 152202Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.00296 AC: 446AN: 150732Hom.: 11 AF XY: 0.00416 AC XY: 333AN XY: 79996
GnomAD4 exome AF: 0.00120 AC: 1679AN: 1396562Hom.: 39 Cov.: 31 AF XY: 0.00177 AC XY: 1221AN XY: 688968
GnomAD4 genome AF: 0.000643 AC: 98AN: 152320Hom.: 2 Cov.: 32 AF XY: 0.000980 AC XY: 73AN XY: 74468
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 13, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2017 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at